Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001839882-23-006255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | SMMT | DUGGAN ROBERT W | CEO, Dir | P - Purchase | $1.05 | +376.49M | 552.35M | +214% | +$395.31M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | P | A | 376,489,880 | $1.05 | 552,354,161 | D | — | — | (F1) Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. |